Influx Healthtech IPO

Influx Healthtech Limited, established in September 2020, is a healthcare-focused company known for its expertise in contract manufacturing. Serving as a dependable CDMO, it offers specialised services across various sectors. Operating three facilities in Thane, Maharashtra, the company covers areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its diverse product range includes tablets, capsules, softgels, jellies, ODFs, effervescent tablets, cosmetics, herbal formulations, veterinary and homecare products. Supporting nutraceutical and cosmetic firms, it provides end-to-end development, production, and regulatory services. As of June 11, 2025, it employs 163 permanent staff.

Influx Healthtech IPO Overview

The Influx Healthtech IPO is a book-built issue worth ₹58.57 crores, comprising a fresh issue of 50 lakh equity shares totalling ₹48.00 crores and an offer for sale of 11 lakh shares amounting to ₹10.56 crores. The IPO will open for subscription on June 18, 2025, and close on June 20, 2025. Allotment is likely to be finalised on June 23, with a tentative listing on NSE SME scheduled for June 25, 2025. The price band is set between ₹91 and ₹96 per share.

The minimum application size for retail investors is 1,200 shares, requiring an investment of ₹1,09,200, though bidding at the cut-off price of ₹1,15,200 is recommended to avoid the risk of missing allotment in case of oversubscription. For HNIs, the minimum investment is two lots (2,400 shares) amounting to ₹2,30,400. Rarever Financial Advisors Pvt. Ltd. is the book-running lead manager, with Maashitla Securities Private Limited acting as registrar. R.K. Stock Holding Private Limited will serve as the market maker.

Influx Healthtech IPO Details

Particulars	Details
IPO Date	18 June 2025 to 20 June 2025
Listing Date	25 June 2025
Face Value	₹10 per share
Issue Price Band	₹91 to ₹96 per share
Lot Size	1200 Shares
Total Issue Size	61,00,800 shares (aggregating up to ₹58.57 Cr)
Fresh Issue	50,00,400 shares (aggregating up to ₹48.00 Cr)
Offer for Sale	11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr)
Issue Type	Bookbuilding IPO
Listing At	NSE SME
Share Holding Pre Issue	1,81,50,000 shares
Share Holding Post Issue	2,31,50,400 shares
Market Maker Portion	3,06,000 shares

Influx Healthtech IPO Reservation

Investor Category	Shares Offered
QIB	Not more than 50% of the Net Issue
Retail	Not less than 35% of the Net Issue
NII (HNI)	Not less than 15% of the Net Issue

Influx Healthtech IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	1	1200	₹1,15,200
Retail (Max)	1	1200	₹1,15,200
HNI (Min)	2	2400	₹2,30,400

Influx Healthtech IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	99.85%
Post-Issue	73.53%

Influx Healthtech IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	7.36
Price/Earnings (P/E) Ratio	TBD
Return on Net Worth (RoNW)	36.98%
Net Asset Value (NAV)	19.91
Return on Equity	36.98%
Return on Capital Employed (ROCE)	49.17%
EBITDA Margin	19.62%
PAT Margin	12.75%
Debt to Equity Ratio	0.01

Objectives of the Proceeds

• Funding capital expenditure requirements for setting up of manufacturing facility for

• Nutraceutical Division ₹2,249.11 lakhs

• Funding capital expenditure requirements for setting up of manufacturing facility for

• Veterinary Food Division ₹1,148.58 lakhs

• Purchase of Machineries for Homecare and Cosmetic Division ₹275.65 lakhs

• Meet general corporate expenses

Key Financials (in ₹ lakhs)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	7029.91	4110.31	2830.42
Revenue	10,485.36	9996.51	7605.55
Profit After Tax	1336.60	1112.80	719.63
Reserves and Surplus	1799.54	2275.44	1162.65
Total Borrowings	21.92	32.48	79.85